Biology Reference
In-Depth Information
Gras GS, Dormont D. 1991. Antibody-dependent and antibody-independent complement-mediated
enhancement of human immunode®ciency virus type 1 infection in a human, Epstein-Barr virus-
transformed B-lymphocytic cell line. J Virol 65: 541±545.
Gras G, Richard Y, Roques P, Olivier R, Dormont D. 1993. Complement and virus speci®c anti-
body dependent infection of normal B lymphocytes by Human Immunode®ciency Virus type 1.
Blood 81: 1808±1818.
Gras G, Legendre C, Krzysiek R, Dormont D, Galanaud P, Richard Y. 1996. CD40/CD40L
interactions and cytokines regulate HIV replication in B cells in vitro. Virology 220: 309±319.
Gri½ths GM, Berek C, Kaartinen M, Milstein C. 1984. Somatic mutation and the maturation of
immune response to 2-phenyl oxazolone. Nature 312: 271±275.
Gringeri A, Santagostino E, Muca-Perja M, Mannucci PM, Zagury JF, Bizzini B, Lachgar A,
Carcagno M, Rappaport J, Criscuolo M, Blattner W, Burny A, Gallo RC, Zagury D. 1998.
Safety and immunogenicity of HIV-1 Tat toxoid in immunocompromised HIV-1-infected
patients [see comments]. J Hum Virol 1: 293±298.
Gringeri A, Santagostino E, Muca-Perja M, Le Buanec H, Bizzini B, Lachgar A, Zagury JF,
Rappaport J, Burny A, Gallo RC, Zagury D. 1999. Tat toxoid as a component of a preventive
vaccine in seronegative subjects. J Acquir Immune De®c Syndr Hum Retrovirol 20: 371±375.
Ha¨ar OK, Smithgall MD, Wong JG, Bradshaw J, Linsley PS. 1995. Human immunode®ciency
virus type 1 infection of CD4 T cells down-regulates the expression of CD28: e¨ect on T cell
activation and cytokine production. Clin Immunol Immunopathol 77: 262±270.
Han S, Zheng B, Schatz DG, Spanopoulou E, Kelsoe G. 1996. Neoteny in lymphocytes: Rag1 and
Rag2 expression in germinal center B cells. Science 274: 2094±2097.
Heath SL, Tew JG, Szakal AK, Burton GF. 1995. Follicular dendritic cells and human immuno-
de®ciency virus infectivity [see comments]. Nature 377: 740±744.
Huang L, Li CJ, Pardee AB. 1997. Human immunode®ciency virus type 1 TAT protein activates B
lymphocytes. Biochem Biophys Res Commun 237: 461±464.
Hufert FT, van Lunzen J, Janossy G, Bertram S, Schmitz J, Haller O, Racz P, von Laer D. 1997.
Germinal centre CD4 T cells are an important site of HIV replication in vivo. AIDS 11: 849±
857.
Jacotot E, Ravagnan L, Loe¿er M, Ferri KF, Vieira HL, Zamzami N, Costantini P, Druillennec
S, Hoebeke J, Briand JP, Irinopoulou T, Daugas E, Susin SA, Cointe D, Xie ZH, Reed JC,
Roques BP, Kroemer G. 2000. The HIV-1 viral protein R induces apoptosis via a direct e¨ect
on the mitochondrial permeability transition pore. J Exp Med 191: 33±46.
Joling P, Bakker LJ, Van-Strijp JAS, Meerloo T, De Graaf L, Dekker MEM, Goudsmit J, Verhoef
J, Schuurman H-J. 1993. Binding of human immunode®ciency virus type-1 to follicular Den-
dritic cells in vitro is complement dependent. J Immunol 150: 1065±1073.
Jourdan P, Abbal C, Noraz N, Hori T, Uchiyama T, Vendrell JP, Bousquet J, Taylor N, Pene J,
Yssel H, Nora N. 1998. IL-4 induces functional cell-surface expression of CXCR4 on human T
cells [published erratum appears in J Immunol 1999; 162: 3105]. J Immunol 160: 4153±4157.
June CH, Bluestone JA, Nadler LM, Thompson CB. 1994. The B7 and CD28 receptor families.
Immunol Today 15: 321±331.
Kacani L, Prodinger WM, Sprinzl GM, Schwendinger MG, Spruth M, Stoiber H, Dopper S,
Steinhuber S, Steindl F, Dierich MP. 2000. Detachment of human immunode®ciency virus type
1 from germinal centers by blocking complement receptor type 2. J Virol 74: 7997±8002.
Kaiser E, Forster R, Wolf I, Ebensperger C, Kuehl WM, Lipp M. 1993. The G protein-coupled
receptor BLR1 is involved in murine B cell di¨erentiation and is also expressed in neuronal
tissues. Eur J Immunol 23: 2532±2539.
Karray S, Zouali M. 1997. Identi®cation of the B cell superantigen-binding site of HIV-1 gp120.
Proc Natl Acad Sci USA 94: 1356±1360.
Search WWH ::




Custom Search